Lind Global Fund II LP - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for NLS Pharmaceuticals Ltd. (NLSP)

Filing Manager
Lind Global Fund II LP
Reporting Manager
Lind Global Fund II LP
Security
NLS Pharmaceuticals Ltd. Common Shares, par value CHF 0.02 per share
Symbol
NLSP
Shares outstanding
1.22M shares
Disclosed Ownership
59.8K shares
Ownership
4.9%
Form type
SCHEDULE 13G/A
Date filed
2/14/2025, 05:08 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Lind Global Fund II LP 4.9% 59.8K 59.8K 0 By: Lind Global Partners II LLC, its General Partner, By: /s/ Jeff Easton Jeff Easton, Managing Member
Lind Global Partners II LLC 4.9% 59.8K 59.8K 0 /s/ Jeff Easton Jeff Easton, Managing Member
EASTON JEFF 4.9% 59.8K 59.8K 0 /s/ Jeff Easton Jeff Easton